what is considered microdosing semaglutide chart: The complete guide Standard Dose vs Microdose GLP-1:

HbA1c staying above target despite metformin Overweight or obesity, especially the abdominal fat pattern common in Indians Existing cardiovascular disease or high cardiac risk a topic we cover in depth in Part 8: GLP-1, Heart and Kidney Benefits Chronic kidney disease, where GLP-1 drugs have shown protective signals [7] A need to avoid hypoglycemia or further weight gain, which older drugs like sulfonylureas often cause DPP-4 inhibitors such as teneligliptin, sitagliptin, vildagliptin, and linagliptin are widely prescribed in India and lower blood glucose with a low risk of hypoglycemia

doi: 10.1159/000454683

Even more, we have specifically tailored the nutritional intervention based on the characteristics of different groups of people

If you are on other medications that are metabolized by these pathways, major drug interactions with sitagliptin are thought to be unlikely